Sign In
Buy AGL
$86.75
-5.79 (-6.26%)
At Close: Jun 02, 2026
New Strong Sell Stocks for November 13th
07:50am, Wednesday, 13'th Nov 2024
AOS, AGL and ABG have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2024.
Agilon Health price target lowered to $2 from $5 at Barclays
05:40am, Monday, 11'th Nov 2024
Barclays lowered the firm's price target on Agilon Health to $2 from $5 and keeps an Underweight rating on the shares. The company's Q3 results underscore the lack of visibility into real-time trends
agilon health, inc. (AGL) Q3 2024 Earnings Call Transcript
04:58am, Sunday, 10'th Nov 2024
agilon health, inc. (NYSE:AGL ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Leland Thomas - Senior Manager-Investor Relations Steven Sell - Chief Executive Office
agilon health Plunges On A Poor Prognosis (Rating Downgrade)
06:52pm, Friday, 08'th Nov 2024
I initially rated agilon health, inc. as a “hold” due to its volatile financial results and uncertain future, but recent developments necessitate a downgrade to 'sell'. The company's stock plummet
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings
07:00pm, Thursday, 07'th Nov 2024
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates
06:30pm, Thursday, 07'th Nov 2024
Agilon Health (AGL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.06 per share a year ago.
agilon health to Participate at 2024 Wolfe Research Healthcare Conference
04:00pm, Tuesday, 05'th Nov 2024
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 W
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL)
agilon health Sets Date to Report Third Quarter 2024 Financial Results
04:00pm, Thursday, 17'th Oct 2024
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial res
agilon health: Interesting Business Model, But Volatile And Uncertain
08:30am, Friday, 16'th Aug 2024
agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company's revenue surged 38.7% year over year, but its net loss nearly double
AGL Energy Limited (AGLNF) Q4 2024 Earnings Call Transcript
02:17am, Wednesday, 14'th Aug 2024
AGL Energy Limited (OTCPK:AGLNF) Q4 2024 Earnings Conference Call August 13, 2024 9:00 PM ET Company Participants Damien Nicks - Managing Director and Chief Executive Officer Gary Brown - Chief Financ
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL)
Magilon health, inc. (AGL) Q2 2024 Earnings Call Transcript
10:20pm, Tuesday, 06'th Aug 2024
Magilon health, inc. (NYSE:AGL ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Leland Thomas - VP, IR Steven Sell - CEO Jeffrey Schwaneke - CFO Conference Call Partic
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
07:36pm, Tuesday, 06'th Aug 2024
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to W
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
06:21pm, Tuesday, 06'th Aug 2024
Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.
